STRATEC Biomedical AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution



STRATEC Biomedical AG 

29.10.2013 18:22

Dissemination of a Voting Rights Announcement, transmitted by DGAP - a company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


1. Threadneedle Asset Management Holdings Limited

Threadneedle Asset Management Holdings Limited, London, UK, has notified us pursuant to sec. 21 para. 1 WpHG on 25 October 2013, that on 23 October 2013 the share of voting rights in STRATEC Biomedical AG, Birkenfeld, Germany, ISIN: DE0007289001 went below the threshold of 5% and that the percentage of voting rights on that day amounted to 4.91% (577,244 voting rights). Threadneedle Asset Management Holdings Limited has notified us that these voting rights of 4.91% (577,244 voting rights) are attributable to Threadneedle Asset Management Holdings Limited pursuant to sec. 22 para. 1 sent. 1 no. 6 in connection with sent. 2 WpHG.

The voting rights were attributed to Threadneedle Asset Management Holdings Limited inter alia from Threadneedle Investment Funds ICVC, being a shareholder holding 3% or more of the voting rights in STRATEC Biomedical AG.


2. Threadneedle Asset Management Limited

Threadneedle Asset Management Limited, London, UK, has notified us pursuant to sec. 21 para. 1 WpHG on 25 October 2013, that on 23 October 2013 the share of voting rights in STRATEC Biomedical AG, Birkenfeld, Germany, ISIN: DE0007289001 went below the threshold of 5% and that the percentage of voting rights on that day amounted to 4.91% (577,244 voting rights). Threadneedle Asset Management Limited has notified us that these voting rights of 4.91% (577,244 voting rights) are attributable to Threadneedle Asset Management Limited pursuant to sec. 22 para. 1 sent. 1 no. 6 WpHG.
The voting rights were attributed to Threadneedle Asset Management Limited inter alia from Threadneedle Investment Funds ICVC, being a shareholder holding 3% or more of the voting rights in STRATEC Biomedical AG.


29.10.2013 DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

 
Language:     English
Company:      STRATEC Biomedical AG
              Gewerbestr. 37
              75217 Birkenfeld
              Germany
Internet:     www.stratec.com
 
End of Announcement DGAP News-Service  




back